Investigating the molecular mechanisms of the “Astragalus-Codonopsis” herb pair in treating diabetes: a network pharmacology and bioinformatics approach with molecular docking validation
Jinliang Yang, Mingyang Li, Ziyue Zhu, Fengling Han, Yanyan Ma, Jinbo Hou, Qingfeng Zhao, Hui Yuan, XiuMei Li
TL;DR
This study explores how the Astragalus-Codonopsis herb pair helps treat diabetes by identifying key compounds and their molecular mechanisms.
Contribution
The study identifies rhamnolitrin and folic acid as key components and reveals their synergistic effects on GSK3β in treating diabetes.
Findings
Rhamnolitrin and folic acid were confirmed as key active components regulating the IRSP pathway in diabetes treatment.
Molecular docking and simulations showed stable binding of these compounds with the GSK3β protein.
Alanine scanning and DFT calculations validated key interactions and binding mechanisms with GSK3β.
Abstract
Astragalus membranaceus and Codonopsis pilosula are widely used in traditional chinese medicine for the treatment of diabetes because of their notable hypoglycemic pharmacological effects. Studies have indicatedthat the active compounds in the Astragalus-Codonopsis herb pair may exert their hypoglycemic effects through the modulation of the insulin receptor (IRSP) signaling pathway. In this study, the rhamnolitrin and folic acid were confirmed as the key active components in the Astragalus-Codonopsis herb pair that regulate the IRSP, with their synergistic mechanisms in Type 2 Diabetes Mellitus (T2DM) being further systematically explored by network pharmacology combined with DFT theoretical calculation, molecular docking, molecular dynamics simulation and alanine scanning mutation technology. The results suggest that GSK3β is a critical target through which rhamnolitrin and folic acid…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Metabolomics and Mass Spectrometry Studies · Bioinformatics and Genomic Networks